Stock Mumak

Stock Profile

ConocoPhillips

ConocoPhillips focuses as a pure upstream player on the exploration and production of oil and gas. The company excels through low break-even costs.

Stock Snapshot

ConocoPhillips Logo
Table HeaderTable Header
CompanyConocoPhillips
SectorEnergy
ThemeExploration & Production (Upstream)
Business ModelExploration, development and production of oil and natural gas ConocoPhillips is one of the world’s largest independent upstream companies and is fully focused on exploration and production—without any downstream or refining business.
ISINUS20825C1045
Market Capitalizationapprox. $147 billion
UMBRELLA StatusActive

This clear structure ensures direct coupling of revenue, cash flow, and profitability to oil and gas price developments.

  • strongly rising free cash flows at stable oil prices
  • low break-even costs (~$40/barrel) → high resilience
  • high capital returns (dividends + buybacks)

→ Key variables: oil/gas prices + production volume + cost structure

Price Performance (12 Months)

Mumak Score Card

Geopolitics

Industry

Fundamentals

Sentiment

Technical Analysis

Aktuelle Unternehmensmeldungen

ConocoPhillips
Company Update

ConocoPhillips – Q1 2026 Earnings Update

Compass 5 out of 5
More research

Latest Portfolio Updates

MUMAK SpotLight

MUMAK SpotLight of the week: Portfolio rotation strengthens technology weighting

More Intel and Micron, exit from Rheinmetall and TKMS: The UMBRELLA Strategy is clearly shifting its focus toward technology.
Next Update
RED HOT CHILI™ MUMAK

RED HOT CHILI™ MUMAK of the Week: Intel – AI momentum is gaining momentum

Intel is the RED HOT CHILI MUMAK™ of the week: Renewed enthusiasm for AI infrastructure, improved sentiment in the semiconductor
Next Update
Weekly Update

Weekly Market Overview – September 14-September 20, 2026

UMBRELLA Strategy: Technology weighting expanded following portfolio adjustments.
Next Update
MUMAK SpotLight

MUMAK SpotLight of the week: Intel becomes part of the UMBRELLA Strategy

Intel was newly added to the UMBRELLA Strategy, expanding the portfolio's semiconductor positioning. At the same time, Revolution Medicines, Bayer,
Next Update